»ÃѺ»Ãا : 7/03/2018
ʶԵԼÙéà¢éÒªÁ:6696638 ¡ÒÃà»Ô´Ë¹éÒàÇçº:9564572 Online User Last 1 hour (0 users)
Protests in Delhi as EU defends Big Pharma
03 ÁÕ¹Ò¤Á 2554
Date: 3 March 2011
Source: www.presseurop.eu
Link:
http://www.presseurop.eu/en/content/news-brief/523991-protests-delhi-eu-defends-big-pharma
“Thousands march in India against EU trade deal,” headlines the EUobserver.
With the EU on the verge of concluding a Free Trade Agreement (FTA) with India,
its largest trading partner, HIV-positive protesters took to the streets of New
Delhi on 2 March concerned that the union is seeking to put an end to the
production of affordable life-prolonging drugs. Since negotiations opened in
2007, the EU has pushed for a “data-exclusivity” clause which would protect
intellectual property rights with respect to drugs. “European drug
manufacturers
complain that many of their patented products are frequently undercut by
generics produced in India,” the Brussels website notes. Data exclusivity would
mean that, clinical trial data filed by one company could not be relied upon by
other companies, “critics argues. As a result, the need for each firm to produce
its own clinical trial tests would dramatically increase the price of
medicines.According to Anand Grover,
the UN Special Rapporteur on the Right to Health, "It would be a colossal
mistake to introduce data exclusivity in India, when millions of people across
the globe depend on the country as the pharmacy of the developing world.”